Rens Schoenmakers

Dialog Semiconductor BV designs, develops, and manufactures semiconductor based system solutions. The company is headquartered in Hertogenbosch, the Netherlands.

Ontwikkelingsmaatschappij Oost Nederland NV (Development Agency East Netherlands) is an Independent Private Equity/Venture Capital firm that focuses its activities on strengthening the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NV is headquartered in Apeldoorn.

Redmedtech Discovery Fund is an independent private equity firm with its headquarters in Apeldoorn, the Netherlands. It was founded in 2014.

BV HealthConnected is a healthcare platform that aims to improve the quality of care by using ICT. The company is based in Alkmaar, Netherlands, and has a clear vision of how ICT can improve healthcare. The platform connects thousands of care providers and millions of patients, and it is designed for primary care, network care, and the entire region. The Dutch company values information security and has a flexible CISO. The company also has an e-learning application and share their success stories and knowledge on various topics through their publications. BV HealthConnected offers vacancies for those who want to contribute to society. Paul Witteman has been the CEO of the company since 2018.

Xilloc Medical Int BV is a Dutch company that manufactures medical instruments, implants, and anatomical models. The company is based in Sittard-Geleen, the Netherlands, and has subsidiaries in the Netherlands. The company was founded in 2003 by Maikel Beerens, and the CEO is Milko Wijckmans.

Sirius Medical BV engages in medical industry. The firm focuses on developing medical devices for oncological surgery. The company was founded by Hubert Martens and Bram Schermers and is headquartered in Eindhoven, the Netherlands.

Holland Capital Management BV (Holland Capital) is an independent private equity & venture capital firm founded in 1981. The firm is headquartered in Amsterdam, the Netherlands.

InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.

Health Innovations BV is an independent private equity firm founded in 2011. The firm is headquartered in Utrecht, the Netherlands.

FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands.

Residex BV is a private equity and venture capital fund manager based in Apeldoorn, Netherlands. Residex traces their history to 1987 when the firm was set up as Participatiemaatschappij BV in The Hague. The current firm was formally established in 1991. Residex is a subsidiary of Achmea Holding NV which provides insurance and financial services. The ultimate parent firm is Eureko BV, which offers insurance services as well as asset management and banking services. Since 1996, Residex focuses on investments in the healthcare sector and specializes in expansion capital, MBOs, MBIs and re-structuring transactions. They manage a number of venture funds with a healthcare/life sciences focus as well as those in biotechnology and the pharmaceutical industries.

Angiogenesis Analytics BV is a Dutch company that aims to improve the diagnosis of prostate cancer by using artificial intelligence technology and ultrasound imaging. The company is based in 's-Hertogenbosch, Netherlands and was founded in 2018 by Mark Bloemendaal, who has been the CEO since then. The company's product, PCaVision, is an ultrasound-based computer aided diagnosis for prostate cancer. The company provides resources in their archive, including documentation of the PCaVision journey from the beginning, awards and grants, and journal articles and theses covering the science behind PCaVision.

Observision, the innovative market leader in security, presents a new generation of integrated security solutions, based on the company's own video and audio technology. With offices in the Netherlands and the United States, and in close cooperation with international systems integrators, they are able to solve highly complex security problems in existing and new (wireless) camera networks. Its customers operate in a wide range of sectors and include police forces, international airports, municipal governments for video surveillance, power stations and road, tunnel, bridge, high-voltage network and industrial complex operators.

Part of Netherlands Foreign Investment Agency, the Dutch company provides investment advisory services.